BioLineRx Ltd (BLRX) — Capital Reinvestment Ratio

Latest as of December 2023: 0.00x

BioLineRx Ltd (BLRX) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow ($4.99 Million) in capital expenditures ($18.00K). See net asset quality index of BioLineRx Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$4.99 Million
USD

Capital Expenditures

$18.00K
USD

Data as of

Dec 2023
Most recent filing

BioLineRx Ltd Capital Reinvestment Ratio (2010–2010)

This chart tracks BioLineRx Ltd's Capital Reinvestment Ratio across 1 annual periods. Check BLRX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for BioLineRx Ltd (2010–2010)

Year-by-year Capital Reinvestment Ratio for BioLineRx Ltd from 2010 to 2010. For live market cap and broader valuation context, see market cap of BioLineRx Ltd.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2010 0.06x $11.46 Million $660.94K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow